Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA

Read more

Lupin receives Great Place To Work certification across global operations

Read more

CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair

Read more

Bayer revises access model for Eylea 2mg in India to expand patient eligibility

Read more

Leading people in the age of AI

Read more

Patent expiries ahead, is India Pharma Inc ready?

Read more

Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India

Read more

Mumbai Experience Center reflects Agilent’s continued commitment to India 

Read more

Lupin completes acquisition of VISUfarma

Read more

Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US

Read more